Navamedic ASA reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was NOK 120.87 million compared to NOK 121.72 million a year ago. Net loss was NOK 1.58 million compared to net income of NOK 13.17 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34 NOK | +2.72% | +1.80% | -7.36% |
May. 06 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
Apr. 30 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.36% | 55.38M | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- NAVA Stock
- News Navamedic ASA
- Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024